Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DU PONT ROYAL : revenue, balance sheet and financial ratios

PHARMACIE DU PONT ROYAL is a French company founded 10 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CREIL (60100), this company of category PME shows in 2018 a revenue of 860 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DU PONT ROYAL (SIREN 819131319)
Indicator 2024 2023 2022 2021 2020 2019 2018
Revenue N/C N/C N/C N/C N/C N/C 859 531 €
Net income 46 754 € 68 350 € 33 250 € 14 203 € 58 320 € 169 968 € 135 464 €
EBITDA N/C N/C N/C N/C N/C N/C 190 734 €
Net margin N/C N/C N/C N/C N/C N/C 15.8%

Revenue and income statement

Im Jahr 2024 erzielt PHARMACIE DU PONT ROYAL ein positives Nettoergebnis von 47 k€. Entwicklung 2018-2024: 135 k€ -> 47 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

46 754 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 0%. Dieses niedrige Niveau spiegelt eine solide Finanzstruktur wider. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 46%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.032%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

46.27%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

4.8%

Solvency indicators evolution
PHARMACIE DU PONT ROYAL

Sector positioning

Verschuldungsgrad
0.03 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Ausgezeichnet

Im Jahr 2024 liegt in den unteren 25% der Branche, was positiv ist das verschuldungsgrad von PHARMACIE DU PONT ROYAL (0.03). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Ein niedriges Verhältnis zeigt eine solide Finanzstruktur mit geringer Abhängigkeit von Gläubigern.

Finanzielle Autonomie
46.27% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average -30 pts over 3 years

Im Jahr 2024 liegt unter dem Median der Branche das finanzielle autonomie von PHARMACIE DU PONT ROYAL (46.3%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Eine Verbesserung würde die Wettbewerbsposition stärken.

Liquidity ratios

Die Liquiditätsquote beträgt 158.44. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

158.437

Liquidity indicators evolution
PHARMACIE DU PONT ROYAL

Sector positioning

Liquiditätsquote
158.44 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average -36 pts over 3 years

Im Jahr 2024 liegt unter dem Median der Branche das liquiditätsquote von PHARMACIE DU PONT ROYAL (158.44). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Eine Verbesserung würde die Wettbewerbsposition stärken.

Working capital requirement (WCR) and payment terms

Der Betriebskapitalbedarf (WCR) misst die zeitliche Lücke.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DU PONT ROYAL

Positioning of PHARMACIE DU PONT ROYAL in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE DU PONT ROYAL is estimated at 652 720 € (range 454 544€ - 976 507€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
454k€ 652k€ 976k€
652 720 € Range: 454 544€ - 976 507€
NAF 5 année 2024

Valuation method used

Net Income Multiple
46 754 € × 14.0x = 652 720 €
Range: 454 544€ - 976 507€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DU PONT ROYAL with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DU PONT ROYAL

What is the revenue of PHARMACIE DU PONT ROYAL ?

The revenue of PHARMACIE DU PONT ROYAL in 2018 is 860 k€.

Is PHARMACIE DU PONT ROYAL profitable?

Yes, PHARMACIE DU PONT ROYAL generated a net profit of 47 k€ in 2024.

Where is the headquarters of PHARMACIE DU PONT ROYAL ?

The headquarters of PHARMACIE DU PONT ROYAL is located in CREIL (60100), in the department Oise.

Where to find the tax return of PHARMACIE DU PONT ROYAL ?

The tax return of PHARMACIE DU PONT ROYAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DU PONT ROYAL operate?

PHARMACIE DU PONT ROYAL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.